US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

271.00

+20.598.22%

Volume:401.89K

Turnover:109.14M

Market Cap:535.09M

PE:- -

High:280.62

Open:265.00

Low:263.72

Close:250.41

52wk High:341.93

52wk Low:77.07

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.85

T/O Rate:20.35%

Dividend:1.00

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Autolus Therapeutics granted RMAT designation for obecabtagene autoleucel

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)

Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)

Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures

Health Care Roundup: Market Talk

HealthCo REIT Director Increases Stake Under Board Unit Plan

Fisher & Paykel Healthcare Issues New Unquoted Employee Options

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett

EBR Systems Says FDA Finds No Need for WiSE System Recall After Cybersecurity Incident

MT Newswires Live

Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

Echo IQ's EchoSolv HF Device Deemed 'Not Substantially Equivalent' by US FDA

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":271,"timestamp":1789671725548,"preClose":250.41,"halted":0,"volume":401892,"delay":0,"changeRate":0.08222515075276549,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Trading","change":20.59,"latestTime":"09-17 15:02:31 EDT","open":265,"high":280.62,"low":263.72,"amount":109137522.25236,"amplitude":0.067489,"askPrice":271.63,"askSize":140,"bidPrice":270.74,"bidSize":40,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.41,"sharesOutstanding":3074486,"nav":250.283,"aum":494179857.69,"dividendRate":0.003696,"bidAskSpread":0.002806,"preHourTrading":{"tag":"盘前","latestPrice":264.96,"preClose":250.41,"latestTime":"09:28 EDT","volume":3396,"amount":879022.60968,"timestamp":1789651729052,"change":14.55,"changeRate":0.058105,"amplitude":0.043329},"postHourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"volumeRatio":1.847683,"impliedVol":0.9332,"impliedVolPercentile":0.5817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.847683,"shares":1974486,"dividePrice":1.0016,"high":280.62,"amplitude":0.067489,"preClose":250.41,"low":263.72,"week52Low":77.07,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":271,"committee":-0.555556,"eps":0,"divideRate":0.003696,"volume":401892,"delay":0,"ttmEps":0,"open":265,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":266,"twentyDayClose":341.55,"sixtyDayClose":235.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666796587","title":"Autolus Therapeutics granted RMAT designation for obecabtagene autoleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2666796587","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666796587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:15","pubTimestamp":1788952531,"startTime":"0","endTime":"0","summary":"Autolus Therapeutics (AUTL) announced that the FDA has granted regenerative medicine advanced therapy, or RMAT, designation to obecabtagene autoleu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-granted-rmat-designation-for-obecabtagene-autoleucel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-granted-rmat-designation-for-obecabtagene-autoleucel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LABU","BK4585","BK4139","LENZ","AUTL","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666769587","title":"Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666769587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666769587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952232,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Collegium Pharmaceutical (COLL), Revolution Medicine...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-collegium-pharmaceutical-coll-revolution-medicines-rvmd-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-collegium-pharmaceutical-coll-revolution-medicines-rvmd-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","LU0109394709.USD","IE00BFTCPJ56.SGD","CANC","BK4007","XLV","LU0889565916.HKD","LABU","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4581","IE00BJT1NW94.SGD","LU1861559042.SGD","PTH","RVMD","BK4139","IE00B2B36J28.USD","LU1861558580.USD","BBH","LU0029874061.USD","IE0009355771.USD","IE0002141913.USD","BK4556","BK4588","NTLA","LU0128526141.USD","IDNA","IE0009354923.USD","BK4535","HCSG","XBI","BK4585","BK4137","COLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666941587","title":"Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666941587","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666941587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Enrollment in LUMINA, the pivotal Phase 2 study of obe-cel in refractory lupus nephritis, is ongoingLONDON and GAITHERSBURG, Md., Sept.  09, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358486/0/en/autolus-therapeutics-announces-fda-rmat-designation-granted-to-obe-cel-for-the-treatment-of-systemic-lupus-erythematosus-and-lupus-nephritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4077","BK4585","LABU","BK4007","SLE","BK4139","BK4588","BK4110","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587949","title":"Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587949","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587949?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"OPGx-BEST1 demonstrated a favorable safety and tolerability profile with no serious adverse events or dose-limiting toxicities observed All five participants demonstrated clinically meaningful improve","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358458/0/en/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-1-2-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","GDOC","MEDX","ARB","IDNA","NVIB","BK4588","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587934","title":"Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587934","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587934?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoing, with a high participation rate and several indicators of improved glycemic control, including a n","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358488/0/en/rezolute-provides-update-on-fda-review-of-its-phase-3-sunrize-study-results-in-congenital-hyperinsulinism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","BK4585","LABU","SOC","LU0128526141.USD","LU2125154935.USD","LU0029874061.USD","HI","LU2360032135.SGD","LU2125154778.USD","BK4588","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458794","title":"X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458794","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458794?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  09, 2026  -- X4 Pharmaceuticals , a company focused on improving the lives of people with rare hematology diseases, today announced that management will participate in a fireside chat at the 2026 Wells Fargo Healthcare Conference on Thursday, September 10, 2026 at 9:30 a.m. ET. A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: Events and Presentations. About X4 Pharmaceuticals X4 Pharmaceuticals is a company focused on improving the lives of people with rare hematology diseases by developing and commercializing innovative therapies in areas with significant unmet needs. Leveraging expertise in diseases of the immune system and CXCR4 biology, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is commercially available in the U.S. as XOLREMDI in its first indication. The Company is currently conducting a global, pivotal Phase 3 clinical trial  evaluating mavorixafor in chron","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358482/0/en/x4-pharmaceuticals-to-participate-in-a-fireside-chat-at-the-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","BK4581","LU0175139822.USD","IE000M9KFDE8.USD","LU1074936037.SGD","LU2236285917.USD","LU1506573853.SGD","XBI","LU1267930227.SGD","LU0310800379.SGD","LU0314106906.USD","LU0417517546.SGD","LU0320765489.SGD","LU1267930490.SGD","LU0130517989.USD","BK4582","LU0072461881.USD","LU0477156953.USD","LU0640476718.USD","LU0708994859.HKD","LU2461242641.AUD","IYF","LU0048573561.USD","LU0310800965.SGD","LU0267386448.USD","LU0029864427.USD","LU1668664300.SGD","FTXO","LU0980610538.SGD","TFNS","LU0787776722.HKD","BK4559","LU0208291251.USD","BK4504","LU0149725797.USD","LU1894683264.USD","LU2361045086.USD","LU0942090050.USD","BK4585","LU1791807156.HKD","LABU","HCSG","LU0251131958.USD","LU0251142724.SGD","LU0868494617.USD","XLV","LU0029874061.USD","KBWB","LU0128525689.USD","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587822","title":"Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587822?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:50","pubTimestamp":1788951011,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Assembly Biosciences (ASMB), Waters (WAT) and Amge...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-waters-wat-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-waters-wat-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4566","BBH","HCSG","LABU","LU0347712357.USD","SG9999001440.SGD","BK4139","BK4533","IBBQ","TBXU","IE00B2B36J28.USD","IE0002141913.USD","LU0122379950.USD","LU1023059063.AUD","GB00B4QBRK32.GBP","LU0889565916.HKD","LU2242646821.SGD","BIB","LU0728928796.USD","BK4581","LU0868494617.USD","PBE","LU2112291526.USD","BK4121","LU2404859741.USD","LU0029874061.USD","ASMB","LU1061106388.HKD","LU0058720904.USD","BK4588","AMGN","BK4585","WAT","LU2404859667.USD","XLV","IBB","LU0690374961.EUR","LU1983299246.USD","LU0320765992.SGD","GB00B4LPDJ14.GBP","LU2242652126.USD","LU2413666699.HKD","LU2089984988.USD","LU0109394709.USD","IE00B4R5TH58.HKD","PJP","LU1721428933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666828455","title":"Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828455","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828455?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358431/0/en/telix-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-and-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","BK4137","LU1363072403.SGD","LU0234570918.USD","LU0795875086.SGD","LU0128526141.USD","ASX","BK4141","LU0006306889.USD","BK4534","LU1074936037.SGD","XLV","LU0106831901.USD","BK4526","LU0053666078.USD","LU2089283258.USD","MS","LU0158827781.USD","LABU","LU1162221912.USD","LU0314104364.USD","LU1244550221.USD","IE00BZ1G4Q59.USD","XBI","LU0158827948.USD","BK4516","IE00B775SV38.USD","BK4127","IE00BKVL7J92.USD","LU0390134368.USD","LU0098860793.USD","BK4504","LU2487616109.SGD","LU1720051017.SGD","LU0106261372.USD","LU2347655156.SGD","LU1668664300.SGD","BK4588","LU1732800096.USD","LU1989772923.USD","TLX","LU2028103732.USD","LU1791710582.SGD","LU0557290698.USD","LU1064131342.USD","IAI","LU1244550494.USD","HCSG","KBWB","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582590","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582590?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:20","pubTimestamp":1788949241,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abbott Laboratories (ABT), Pharvaris (PHVS) and Zi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pharvaris-phvs-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pharvaris-phvs-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1691799644.USD","HCSG","LU0170899867.USD","LABU","LU0310799852.SGD","LU1201861249.SGD","IE00B19Z3B42.SGD","TMED","IE00B2B36J28.USD","IE0002270589.USD","LU1023059063.AUD","LU1914381329.SGD","LU0648001328.SGD","LU0234572021.USD","LU0882574055.USD","ABT","IHI","LU1670628061.USD","LU1989763690.USD","LU2237957811.SGD","LU1267930573.SGD","LU2211815571.USD","LU0432979614.USD","LU1061106388.HKD","LU0211327993.USD","ZBH","LU0130102774.USD","LU0889566641.SGD","BK4585","PHVS","SGXZ23171101.USD","XLV","BK4007","BK4082","IE00B19Z3581.USD","LU2089984988.USD","LU0980610538.SGD","LU2133065610.SGD","LU0211328371.USD","LU0029864427.USD","PJP","BK4592","LU0128526141.USD","LU0320765489.SGD","LU0114720955.EUR","LU0708994859.HKD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582848","title":"RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582848?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:00","pubTimestamp":1788948000,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Sept.  09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358410/10985/en/radnet-inc-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-on-wednesday-september-16th-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","XLV","HCSG","BK4137","BK4581","BK4585","XBI","BK4588","LU0128526141.USD","LU2065731478.USD","RDNT","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584832","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584832?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:50","pubTimestamp":1788947417,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Surrozen (SRZN), Liquidia Technologies (LQDA) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-surrozen-srzn-liquidia-technologies-lqda-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-surrozen-srzn-liquidia-technologies-lqda-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRZN","XLV","LU0128526141.USD","BK4137","BK4139","BK4581","UHS","BK4007","BK4185","BK4588","HCSG","LQDA","XBI","LU0029874061.USD","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589965","title":"Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589965","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:11","pubTimestamp":1788945080,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has issued an update. Bamboos Health Care Holdings Ltd has issued a profit warning, indicating net ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4585","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158565","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666158565?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:20","pubTimestamp":1788942000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0801 GMT - Novartis's latest clinical-trial setback raises quest","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XLV","BK4581","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666588523","title":"HealthCo REIT Director Increases Stake Under Board Unit Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666588523","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666588523?lang=en_us&edition=fundamental","pubTime":"2026-09-09 15:08","pubTimestamp":1788937697,"startTime":"0","endTime":"0","summary":"An announcement from HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) is now available. HealthCo Healthcare & Wellness REIT disclosed a change in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-reit-director-increases-stake-under-board-unit-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-reit-director-increases-stake-under-board-unit-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDIV","DFRA","BK4588","IQRA","PSCF","REIT","RJMG","XBI","RNTY","BK4581","BPRE","YLDW","IVRA","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530127","title":"Fisher & Paykel Healthcare Issues New Unquoted Employee Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530127?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:17","pubTimestamp":1788923854,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an update. Fisher & Paykel Healthcare Corporation Limited has notified t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","BK4585","XLV","BK8004","FPH.NZ","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630973","title":"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630973?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:30","pubTimestamp":1788921013,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU1861558580.USD","LU0029874061.USD","LABU","AMGN","LU1983299246.USD","LU2242652126.USD","BEAM","SG9999001440.SGD","BK4533","LU0868494617.USD","IE0002141913.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","RPRX","PBE","IBBQ","IE00B2B36J28.USD","TBXU","BK4139","BK4534","LU0289739699.SGD","IBB","IHE","LU1861559042.SGD","BK4588","HCSG","IE00B4R5TH58.HKD","BK4137","BIB","BK4566","IE0009355771.USD","LU1061106388.HKD","XBI","BK4599","BK4505","BK4535","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4611","IE00BJT1NW94.SGD","PJP","LU1023059063.AUD","LU1057294990.SGD","BK4007","LU2242646821.SGD","XLV","LU0889565916.HKD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309940","title":"Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309940?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:06","pubTimestamp":1788919570,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst maintained a Sell rating on Ramsay Health Care today and set a price target of A$48.00. In addition to Ord Minnett, Ramsay Heal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4581","BK4185","RMSYF","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630529","title":"EBR Systems Says FDA Finds No Need for WiSE System Recall After Cybersecurity Incident","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630529","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630529?lang=en_us&edition=fundamental","pubTime":"2026-09-09 09:02","pubTimestamp":1788915728,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  has completed its review of the company's cybersecurity risk assessment related to the February incident and determined that no field corrective action or recall of the WiSE System is warranted, according to a Wednesday filing with the Australian bourse.The incident was classified as a controlled risk under FDA postmarket cybersecurity guidance, with no evidence of any impact on the safety or performance of fielded WiSE cardiac resynchronization therapy systems, per the filing.The company continues its cybersecurity remediation efforts by strengthening credential controls, enhancing anti-phishing measures, expanding endpoint monitoring, hardening its products, and providing required updates to the FDA, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","CIBR","BUG","BK4588","BK7007","EBR.AU","IHAK","HACK","NTSK","TEKX","BK4097","LABU","HAKY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370726","title":"Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370726?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:59","pubTimestamp":1788904740,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) (\"Inhibitor\" or the \"Company\") today highlighted several important developments disclosed in its Quarterly Re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","BK4585","LABU","BK4139","BK4539","BK4588","R","BK4007","INTI","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370799","title":"Echo IQ's EchoSolv HF Device Deemed 'Not Substantially Equivalent' by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370799","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370799?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:58","pubTimestamp":1788904705,"startTime":"0","endTime":"0","summary":"Echo IQ  failed to secure commercial clearance for its EchoSolv HF device after the US Food and Drug Administration  found its initial 510 application  \"not substantially equivalent,\" according to an Australian bourse filing on Tuesday after market hours.The company is evaluating the US FDA's concerns with regulatory, legal, and statistical advisers and believes a potential pathway to clearance remains, per the filing.An applicant whose medical device has been deemed not substantially equivalent may resubmit another 510 application with new data, request a Class I or II designation, file a reclassification petition, or submit a premarket approval application, according to the FDA's website.The decision does not affect the FDA-cleared EchoSolv AS platform or its commercialization in the US, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","EIQ.AU","BK4585","BK7016"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":14,"totalSize":396,"code":"91000000","status":"200"}]}}